The news comes at the end of a busy year for Cleerly. The company says it will use the funds to grow commercially and generate more evidence in support of its FDA-approved technology.

The news comes just days after CMS confirmed these technologies would start receiving expanded Medicare coverage in November. HeartFlow and other AI vendors have already shared their excitement over the decision. 

Prior authorization is frustrating to clinicians, but a new survey from the American Medical Association shows it also frustrates patients to the point of abandoning care. The survey showed many more insights regarding PA impact on care.

Buzzworthy developments of the past few days.

The past five years have been boom times for AI startups courting venture investors in healthcare, and the good times just keep rolling.

Now that the company has gained FDA approval for multiple algorithms, Eko Health aims to reach as many patients as possible with its AI-powered devices.

Around the world, 3 of 4 workers who routinely handle information are now using generative AI on the job. And almost half of them are new to the technology, having begun using it only over the past half-year.

Dave Walker, senior director of revenue cycle, Radiology Associates of North Texas, explains how his practice uses artificial intelligence for revenue cycle management during the Radiology Business Management Association (RBMA) 2024 meeting.